DENTAL INSURANCE ASSIGNABILITY

Engrossed on 4/9/25

Summary

Amendment can translate this bill from legal jargon into easy-to-understand language. Sign up to try it for free.

  • Takes 30 seconds
  • Free
  • No credit card required

From the Legislature

Creates the Patient Access to Pharmacy Protection Act. Provides that no person, including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless the receipt is prohibited by federal law; impose any restriction on the ability of a 340B covered entity to contract with or designate a 340B contract pharmacy; or require or compel a 340B covered entity or 340B contract pharmacy to perform the specified actions. Provides that each individual transaction of 340B drugs that is subject to a prohibited act, as specified, shall constitute a separate violation of the Act. Sets forth provisions concerning reporting requirements for a 340B covered entity and the Department of Healthcare and Family Services; 340B prescription drug applicability; preventing duplication of 340B discounts; enforcement of the Act by the Attorney General; penalties; and preemption. Effective immediately.

Sponsors

DDDDDDDDDDDDDDDDDDDDDDDDDD
26
4
RRRR
Democratic CaucusRepublican Caucus

Roll Call Votes

55 Yea

RDRRDRDRRRDRDDDDRDRDRRDDDDDRDDDDDDDDDRDDDDDDDRDRRDRDRDD

0 Nay

4 Not Voting

DDDD

Calendar

Mar 4, 2025

2:00 PM

Insurance Committee Hearing

Mar 11, 2025

2:00 PM

Insurance Committee Hearing

Mar 18, 2025

2:00 PM

Insurance Committee Hearing

Mar 20, 2025

2:00 PM

Insurance Committee Hearing

Mar 25, 2025

2:00 PM

Insurance Committee Hearing

Apr 8, 2025

2:00 PM

Insurance Committee Hearing

Apr 9, 2025

5:00 PM

Insurance Committee Hearing

May 14, 2025

2:00 PM

Executive Committee Hearing

May 28, 2025

2:00 PM

Executive Committee Hearing

May 30, 2025

2:00 PM

Executive Committee Hearing